CD274 and Ascites: Cohort 1 encompassed 9 pairs of pre‐treatment baseline and post‐treatment progression samples of ascites with a follow‐up period ranging from 11 to 181 days, in which four patients received chemotherapy and five underwent immunotherapy (anti‐PD‐1/PD‐L1) (Figure 1B, Table S4).